ActiViews

CT-guided Lung Biopsy Device

Acquired by Stryker Corporation
Acquired Haifa, Israel Founded 2006
Last updated 2026-06-18
Total raised
$10.0M
Last: 2010-01
Stage
Acquired
Founded
2006
Headcount
6
HQ
Haifa, Israel
Sector

About

ActiViews, a medical device company, develops, manufactures and markets surgical navigation solutions.

Funding history · 2 rounds · $10.0M total

Q&A

What is ActiViews' primary business?
ActiViews is a medical device company that develops, manufactures, and markets surgical navigation solutions, specifically a CT-guided Lung Biopsy Device.
When was ActiViews founded?
ActiViews was founded in January 2006.
What is the total amount of funding ActiViews has raised?
ActiViews has raised a total of $10,000,000 USD.
When was ActiViews' last funding round and who were the investors?
ActiViews' last funding round was in January 2010. Investors included 7 Health Ventures and Ofer Hi-Tech.
Who acquired ActiViews and when?
ActiViews was acquired by Stryker Corporation in October 2013.
Where is ActiViews headquartered?
ActiViews is headquartered in Haifa, North District, Israel.
Who are the co-founders of ActiViews?
The co-founders of ActiViews are Pinchas Gilboa and Yuval Zuk.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

videosoftware-applicationsdiagnosticspulmonarybiopharmaceuticalhospitalssurgical-instrumentsct-scanmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Facebookfacebook.com/ActiViews-168939713171897

Identifiers & details

Founded2006-1
Employees (exact)6
Status reasonAcquired (Inactive) by Stryker Corporation on Oct 2013 - closed due to acquisition

Acquisitions & public offerings

Acquired by Stryker Corporation 2013-10

Radar intelligence

Patents

EPO5